This bill lowers the age for mandatory annual mammogram coverage under large group health insurance plans from 35 to 30 years old. It directly affects women aged 30-39 enrolled in large employer-sponsored health plans. The key change modifies insurance law to require annual mammograms for this age group in large plans (previously only for ages 35-39), though coverage remains subject to physician recommendation and medical necessity determination. This policy update applies to all large group health insurance policies issued or renewed after the effective date.
This bill requires insurance companies to cover at least 90 days of rehabilitation services at a facility when a doctor prescribes it. It directly affects insured individuals needing post-illness or injury rehabilitation, ensuring they receive extended coverage without arbitrary limits. The key provision mandates that new or renewed insurance policies include this 90-day coverage, contingent on a doctor's referral. The law takes effect 90 days after enactment and applies to policies issued after that date.
S 2080 expands New York's assault law to protect more healthcare workers and hospital volunteers, including registered nurses, nurse practitioners, and certified nursing assistants, when they are performing their duties. It also extends these protections to transit workers like bus drivers, train operators, and station cleaners during official duties. The bill amends two sections of the penal law (subdivisions 3 and 11 of section 120.05) to add these new categories to the list of protected individuals. This change directly affects medical and transit workers by making it a crime to assault them while on duty, strengthening legal safeguards for essential frontline staff.
This bill creates a state-funded program to improve healthcare quality in home care settings. It provides grants or supplemental payments to certified home health agencies, long-term home care programs, and managed care plans that partner with home care providers. The program supports specific quality improvements like falls prevention, care coordination with hospitals, technology integration for better patient monitoring, staff training, and evidence-based practices. These initiatives aim to enhance patient outcomes, reduce health disparities, and align home care with broader healthcare systems. The program requires the health commissioner to establish application and scoring processes with input from home care providers and managed care plans.
Relates to veterans' health care; creates a veteran health care review to ensure veterans and their families have access to health and mental health treatment, including for post-traumatic stress disorder, depression, anxiety, military sexual trauma, reproductive and mental health conditions, and suicide prevention.
This bill requires health insurance plans to cover at least one abuse-deterrent opioid pain medication for each active ingredient used to treat pain. It ensures patients pay no more for these abuse-deterrent options than for non-abuse-deterrent opioids (e.g., same copay level), and prohibits insurers from increasing patient costs or creating barriers to access these medications. The law also prevents prior authorization rules from forcing patients to try non-abuse-deterrent opioids first to get access to abuse-deterrent versions. It directly affects patients prescribed opioid pain medications and all health insurance plans operating in New York. The policy aims to improve access to medications designed to reduce opioid misuse without increasing out-of-pocket costs for patients.
This bill requires medical assistance programs to cover implantable infusion pumps for chronic non-cancer pain management as a standard benefit. It adds these pumps - devices that deliver pain medication directly to the spinal cord - to the list of mandatory covered treatments under social services law. The change would directly affect medical assistance recipients with qualifying chronic pain conditions who currently lack guaranteed access to this treatment option. The law would take effect on July 1, 2025, if passed.
This bill allows preschools to keep epinephrine auto-injector devices (for severe allergic reactions) on-site. It directly affects preschool facilities and their staff by expanding existing public health law to explicitly include preschools in the list of authorized locations for these devices. The key change adds "pre-school facilities" to the current list of places permitted to have such emergency allergy equipment, alongside schools, camps, and other childcare settings. This makes it easier for preschools to quickly access life-saving treatment during allergic emergencies.
Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.
Requires public hospitals to establish auto-immune disease treatment centers; authorizes the commissioner of health, with the assistance of the office of health equity, to make funds available to public hospitals for such purpose.
